Clinical trials
Sjogren's Syndrome trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 11 |
| 2025 | 6 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
| Completed | 9 |
| Unknown status | 8 |
| Not yet recruiting | 6 |
| Active, not recruiting | 4 |
| Suspended | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Peking Union Medical College Hospital | 6 |
| Peking University People's Hospital | 4 |
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 3 |
| Nanjing Bioheng Biotech Co., Ltd. | 3 |
| Essen Biotech | 2 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2 |
| Peking University Third Hospital | 2 |
| Shanghai Changzheng Hospital | 2 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sjogren's Syndrome | 53 |
| Lupus Erythematosus, Systemic | 21 |
| Scleroderma, Systemic | 19 |
| Myositis | 17 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 16 |
| Antiphospholipid Syndrome | 11 |
| Autoimmune Diseases | 10 |
| Dry Eye Syndromes | 5 |
| Arthritis, Rheumatoid | 2 |
| Dermatomyositis | 2 |
Trials
Showing 51 to 53 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.